Home›Stock Screener›Alkem Laboratories›Quarterly Results

Alkem Laboratories Quarterly Results

Latest Quarter Net Profit
₹251 Cr
QMar 2026
Quarterly Results

Alkem Laboratories quarterly results. In Mar 2026, Alkem Laboratories (ALKEM) reported revenue ₹3,803 Cr and net profit ₹251 Cr — revenue +15.6% YoY. Review Alkem Laboratories P/E valuation to evaluate earnings-based valuation against sector peers.

ALKEM Quarterly Results — Revenue, Profit & EPS Highlights

Alkem Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check ALKEM market cap trends to track the company's total market size over time.

  • Revenue of ₹3,803 Cr in Mar 2026 (-2.3% vs Jun 2026, +15.6% vs Mar 2025)
  • Net Profit of ₹251 Cr in Mar 2026 (-51.8% vs Jun 2026, -22.0% vs Mar 2025)
  • EBITDA of ₹583 Cr in Mar 2026 (-36.6% vs Jun 2026)
  • Operating Margin of 11.0% in Mar 2026 (-9.0pp vs Jun 2026)
  • Earnings Per Share of ₹19.77 in Mar 2026 (-54.5% vs Jun 2026)

Alkem Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ALKEM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 3,803 3,893 4,105 3,290 3,521 -2.3% 15.6%
Net Profit (₹ Cr) 251 521 779 322 668 - -
EBITDA (₹ Cr) 583 919 1,025 537 889 - -
EPS (₹) 19.77 43.49 63.99 25.57 55.56 - -
Operating Margin (%) 11.0% 20.0% 23.0% 12.0% 22.0% - -

ALKEM Share Price Trend — 1-Year Movement Across Quarterly Results

Alkem Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Alkem Laboratories screener.

Profitability Ratios

Profit Margin 6.6%
EBITDA Margin 15.3%
Operating Margin 11.0%
ROE (Annual) 7.0%

Balance Sheet Highlights

Total Assets ₹20,873 Cr
Total Equity ₹14,349 Cr
Current Assets ₹ Cr
Current Liabilities ₹1,741 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,963 Cr
Investing Cash Flow ₹-1,682 Cr
Financing Cash Flow ₹-503 Cr
Net Cash Flow ₹-222 Cr

Current Market Data

Current Price ₹5013.50
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 3,290
Sept 2025 4,105
Jun 2026 3,893
Mar 2026 3,803

Net Profit Trend (₹ Cr)

Mar 2025 322
Sept 2025 779
Jun 2026 521
Mar 2026 251

Operating Margin Trend (%)

Mar 2025 12.0%
Sept 2025 23.0%
Jun 2026 20.0%
Mar 2026 11.0%

ALKEM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Alkem Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1758.0 15,018 2,710 -5.6% - 18.0% 155.6
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 9162.0 2,986 751 -5.0% - 25.2% 323.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1135.0 7,569 1,341 -4.3% - 17.7% 89.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores